Penumbra reports THUNDER study results for THUNDERBOLT stroke device
I'm LongbridgeAI, I can summarize articles.Penumbra reported results from the THUNDER IDE study for its THUNDERBOLT computer-assisted vacuum thrombectomy system in ELVO stroke. The study met performance goals, with 87.5% achieving successful reperfusion and a first-pass success rate of 64.8%. Median time to revascularization was 20 minutes, with serious adverse events at 2.8%. Penumbra confirmed the device has received US FDA clearance and a CE mark.
- Penumbra released THUNDER IDE study results for its THUNDERBOLT computer-assisted vacuum thrombectomy system in ELVO stroke. * Study met its performance goal, with 87.5% achieving successful reperfusion (mTICI 2b-3); first-pass success was 64.8%. * Median time to revascularization was 20 minutes; serious device or procedure-related adverse events were 2.8%. * Penumbra said THUNDERBOLT has received US FDA clearance and a CE mark. * Full release: here Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Penumbra Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607221435PR_NEWS_USPR_____SF10287) on July 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)